| Financial Year |
March 31 2023 |
| Monetary Funds |
82,758,938.33 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,218,306.87 |
| Accounts Receivable |
364,484,668.21 |
| Advances to Suppliers |
9,133,744.84 |
| Other Receivables |
31,173,432.74 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
70,596,780.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
21,039,089.72 |
| Other Current Assets |
48,637,899.02 |
| Total Current Assets |
881,301,167.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
7,995,701.45 |
| Long-term Equity Investment |
466,881,420.70 |
| Investment Properties |
13,556,596.02 |
| Fixed Assetes |
261,506,374.86 |
| Under-construction Projects |
36,063,905.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,046,767.89 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,163,143.98 |
| Deferred Income Tax Assets |
83,724,744.47 |
| Other Non-Current Assets |
1,419,344,916.49 |
| Sub-Total of Non-Current Assets |
2,343,294,125.17 |
| Total Assets |
3,224,595,292.69 |
| Short-Term Loans |
484,350,829.10 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,450,000.00 |
| Accounts Payable |
330,028,144.14 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
27,034,471.81 |
| Taxes Payable |
25,301,877.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
202,686,201.55 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
113,119,463.11 |
| Other Current Liabilities |
39,721,682.23 |
| Sub-Total of Current Liabilities |
1,392,109,356.17 |
| Long-term Loans |
643,594,079.87 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,564,865.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
27,331,355.53 |
| Other Non-Current Liabilities |
99,474,572.50 |
| Sub-Total of Non-Current Liabilities |
776,155,920.54 |
| Total Liabilities |
2,168,265,276.71 |
| Paid-In Capital(Or Share Stock) |
1,031,548,540.00 |
| Capital Surplus |
63,520,512.20 |
| Surplus Reserve |
66,624,667.48 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-118,279,506.52 |
| Minority Stockholder's Interest |
12,425,705.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,043,904,310.73 |
| Owner's Equity（Stockholder's Equity） |
1,056,330,015.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,224,595,292.69 |
